Assessment of Preanalytical Cerebrospinal Fluid Handling and Storage Factors on Measurement of Aβ1-42, Aβ1-40, and pTau181 Using an Automated Chemiluminescent Platform.


Journal article


Sara Ho, Jacqueline A. Darrow, Francesca De Simone, Amanda Calabro, Sara J. Gannon, Rianne N Esquivel, Parmi Thakker, Kristina Khingelova, Aruna Rao, Yifan Zhang, A. Moghekar
The Journal of Applied Laboratory Medicine, 2024

Semantic Scholar DOI PubMed
Cite

Cite

APA   Click to copy
Ho, S., Darrow, J. A., Simone, F. D., Calabro, A., Gannon, S. J., Esquivel, R. N., … Moghekar, A. (2024). Assessment of Preanalytical Cerebrospinal Fluid Handling and Storage Factors on Measurement of Aβ1-42, Aβ1-40, and pTau181 Using an Automated Chemiluminescent Platform. The Journal of Applied Laboratory Medicine.


Chicago/Turabian   Click to copy
Ho, Sara, Jacqueline A. Darrow, Francesca De Simone, Amanda Calabro, Sara J. Gannon, Rianne N Esquivel, Parmi Thakker, et al. “Assessment of Preanalytical Cerebrospinal Fluid Handling and Storage Factors on Measurement of Aβ1-42, Aβ1-40, and pTau181 Using an Automated Chemiluminescent Platform.” The Journal of Applied Laboratory Medicine (2024).


MLA   Click to copy
Ho, Sara, et al. “Assessment of Preanalytical Cerebrospinal Fluid Handling and Storage Factors on Measurement of Aβ1-42, Aβ1-40, and pTau181 Using an Automated Chemiluminescent Platform.” The Journal of Applied Laboratory Medicine, 2024.


BibTeX   Click to copy

@article{sara2024a,
  title = {Assessment of Preanalytical Cerebrospinal Fluid Handling and Storage Factors on Measurement of Aβ1-42, Aβ1-40, and pTau181 Using an Automated Chemiluminescent Platform.},
  year = {2024},
  journal = {The Journal of Applied Laboratory Medicine},
  author = {Ho, Sara and Darrow, Jacqueline A. and Simone, Francesca De and Calabro, Amanda and Gannon, Sara J. and Esquivel, Rianne N and Thakker, Parmi and Khingelova, Kristina and Rao, Aruna and Zhang, Yifan and Moghekar, A.}
}

Abstract

BACKGROUND Standardizing cerebrospinal fluid (CSF) laboratory protocols will improve the reliability and availability of clinical biomarker testing required for prescription of novel Alzheimer disease (AD) therapies. This study evaluated several preanalytical handling and storage factors common to β-amyloid1-42 (Aβ1-42), β-amyloid1-40 (Aβ1-40), and phosphorylated tau (pTau181) concentrations including storage at different temperatures, extended cap contact, various mixing methods, and multiple freeze-thaw cycles.

METHODS Aβ1-42, Aβ1-40, and pTau181 concentrations were measured using LUMIPULSE G1200 automated assays. Samples were collected in polypropylene tubes of various volumes. Sample cap-contact was evaluated by storing samples in upright and inverted positions at either 4°C for 1 week or -80°C for 1 month. To assess mixing methods, samples were freeze-thawed and mixed by inversion, vortex, horizontal roller, or unmixed prior to assay sampling. The impact of successive freeze-thaw cycles was assessed through freezing, thawing, and analyzing CSF samples.

RESULTS Short-term storage at 4°C did not affect Aβ1-42, Aβ1-40, or pTau181 measurements in any tube type. Tube cap contact affected Aβ1-42 in 2.5 mL tubes and pTau181 levels in 10 mL tubes. No difference was observed between mixing methods. After 4 freeze-thaw cycles, Aβ1-42 significantly decreased but Aβ1-40 remained unchanged. Utilizing the Aβ1-42/Aβ1-40 ratio, Aβ1-42 values normalized, maintaining ratio values within ±5% of baseline measurements.

CONCLUSIONS Storage of CSF at 4°C for 1 week or -80°C for 1 month did not significantly affect Aβ1-42, Aβ1-40, pTau181, or associated ratio measurements. Tube cap-contact impacted pTau181 and pTau181/Aβ1-42 values in larger tubes. Mixing methods are equivalent. The Aβ1-42/Aβ1-40 ratio compensates for freeze-thaw variability up to 4 cycles.



Tools
Translate to